SynthesisDigestive diseases and sciences2026
Efficacy of Whole-Food Based Anti-inflammatory Dietary Interventions in the Management of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Synthesis in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mirikizumab: a landmark in IL-23-targeted therapy for ulcerative colitis.Annals of medicine and surgery (2012) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUlcerative Colitis (UC) is a chronic inflammatory colon condition with multifactorial causation. Recent interest has grown around the role of diet in managing symptoms and disease progression. Due to the absence of definitive evidence, no consistent dietary guidelines exist for UC management.
aimsThis research investigates the impact of anti-inflammatory diets on disease activity and inflammation in patients with UC.
methodsPubMed, Cochrane, Embase and ClinicalTrials.gov were systematically searched from inception until April 2025. Dichotomous outcomes were pooled as risk ratio (RR) and continuous outcomes as mean differences (MD) with 95% confidence intervals (CI), using random-effects models. Heterogeneity was assessed using I
resultsSix RCTs involving 359 patients aged 12-75 years, having mild-to-moderate active UC, quiescent UC or UC in clinical remission, were included. Anti-inflammatory diets did not significantly affect the clinical remission (RR = 1.59, 95% CI [0.77 to 3.28], P = 0.21, I
conclusionAnti-inflammatory diet complements conventional therapy in UC by promoting clinical response in active disease and reducing intestinal inflammation during remission.
Indexed as
Identifiers
40797000What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.